Melanie M. Smith

Melanie M. Smith

Auto-generated profile, based on publicly available information

Melanie M. Smith

Northwestern University Feinberg School of Medicine, Chicago, IL, United States

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in American Journal of Hospice and Palliative Medicine®
Verified
Journal Article
Closed access
MSMelanie M. Smith
Melanie M. Smith
KSKatharine E. Secunda
Katharine E. Secunda
ECElaine R. Cohen
Elaine R. Cohen
DWDiane B. Wayne
Diane B. Wayne
JVJulia H. Vermylen
Julia H. Vermylen
GWGordon J. Wood
Gordon J. Wood
Background: It is unknown whether traditional medical education ensures competence among fellows in the key skill of breaking bad news (BBN). While simulation-based mastery learning (SBML) has been used to train fourth-year medical students (M4s) in BBN, it is unclear if it adds similar value for fellows. Objective: We examined the effect of traditional medical training on BBN skills by comparing baseline fellow and M4 skills and confidence and assessed the impact of a BBN SBML curriculum for fellows. Methods: Fellows training in six programs at Northwestern University from November 2018 to May 2019 were eligible for inclusion. Fellows completed a BBN SBML curriculum including a pretest, individualized feedback using a previously published assessment tool, and ongoing deliberate practice until all achieved a minimum passing standard (MPS). The primary outcomes were checklist and scaled item scores on the assessment tool. Fellow performance was compared to a historical M4 cohort. Results: Twenty-eight of 38 eligible fellows completed the curriculum and were included for analysis. Fellows reported significantly more experience and confidence in BBN compared to M4s, yet their pre-training performance was significantly worse on checklist (57.1% vs 65.0%, P = .02) and scaled items; only 4% reached the MPS. After training, fellow performance significantly improved on checklist (57.1% to 92.6%, SD = 5.2%, P < .001) and scaled items; all reached the MPS. Conclusions: Despite higher confidence and BBN clinical experience, fellows performed worse than untrained M4s, confirming that experience is not a proxy for skill. Programs must develop competency-based assessments to ensure entrustment of communication skills.

24 March 2024 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
JWJames M. Walter
James M. Walter
MSMelanie M. Smith
Melanie M. Smith
NENoah Einstein
Noah Einstein
ECElaine R. Cohen
Elaine R. Cohen
GWGordon J. Wood
Gordon J. Wood
JVJulia H. Vermylen
Julia H. Vermylen

17 June 2025 in Chest
Verified
Journal Article
Closed access
MSMelanie M. Smith
Melanie M. Smith
JWJames M. Walter
James M. Walter
NMNatalie K. Munger
Natalie K. Munger
ECElaine R. Cohen
Elaine R. Cohen
JVJulia H. Vermylen
Julia H. Vermylen
GWGordon J. Wood
Gordon J. Wood

21 November 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SASaki Amagai
Saki Amagai
AHAlexandra Harris
Alexandra Harris
NMNisha Mohindra
Nisha Mohindra
SKSheetal Kircher
Sheetal Kircher
JLJeffrey A Linder
Jeffrey A Linder
NJNeil Jordan
Neil Jordan
Background: The US health care system faces escalating costs, increasing emphasis on patient autonomy, and a regulatory shift toward patient-centered care and patient-reported outcomes (PROs). Leveraging PROs to support shared decision-making has the potential to improve outcomes and reduce health care use for patients with advanced chronic conditions. Objective: This study aims to evaluate the impact of a PRO-based clinical dashboard on the use of costly health services among patients with advanced cancer and chronic kidney disease (CKD). Methods: We conducted a quasi-experimental, propensity score–weighted, difference-in-differences analysis using routinely collected data (June 2020 to January 2022) from a large US academic health system. Dashboard users were compared with contemporaneous nonexposed patients matched on clinical criteria. The primary outcomes were unplanned all-cause hospital admissions, potentially avoidable emergency department visits, excess days in acute care within 30 days of discharge, and 7-day readmissions. Cancer-specific secondary outcomes included acute encounters during outpatient chemotherapy, oncology triage use, advance directive completion, and hospice use. CKD-specific outcomes were CKD-related acute care use and disease progression. Results: In the advanced cancer cohort (dashboard users: n=284; dashboard nonusers: n=917), dashboard use was associated with significantly fewer chemotherapy-related emergency department or hospital encounters (ratio-in–odds ratios 0.35, 95% CI 0.16-0.75) and a nonsignificant 1.7–percentage point reduction in unplanned admissions (β=–0.017, 95% CI –0.107 to 0.072). Using Firth penalized logistic regression to reduce small sample bias, dashboard use was also associated with significantly higher odds of 7-day readmissions (ratio-in–odds ratios 8.58, 95% CI 2.28-32.32). Among readmissions in the dashboard user group, most (13/14, 93%) were scheduled by clinicians. Excess days in acute care increased by 4 percentage points (β=0.040, 95% CI –0.001 to 0.089). Advance directive completion declined significantly (β=–0.009, 95% CI –0.039 to 0.020). In the CKD cohort (dashboard users: n=365; dashboard nonusers: n=2137), no significant differences were observed for any primary or CKD-specific outcome. Conclusions: In routine oncology practice, a PRO dashboard was associated with fewer acute care encounters during chemotherapy but more planned early readmissions. The dashboard had no measurable effect on patients with CKD. These disease-specific mixed results highlight the need to tailor dashboards to the clinical context and embed them within workflows that can act on real-time PRO information.

21 December 2024 in JMIR Preprints
Verified
Preprint
Open access
SASaki Amagai
Saki Amagai
AHAlexandra Harris
Alexandra Harris
NMNisha Mohindra
Nisha Mohindra
SKSheetal Kircher
Sheetal Kircher
JLJeffrey A Linder
Jeffrey A Linder
NJNeil Jordan
Neil Jordan
BACKGROUND The US health care system faces escalating costs, increasing emphasis on patient autonomy, and a regulatory shift toward patient-centered care and patient-reported outcomes (PROs). Leveraging PROs to support shared decision-making has the potential to improve outcomes and reduce health care use for patients with advanced chronic conditions. OBJECTIVE This study aims to evaluate the impact of a PRO-based clinical dashboard on the use of costly health services among patients with advanced cancer and chronic kidney disease (CKD). METHODS We conducted a quasi-experimental, propensity score–weighted, difference-in-differences analysis using routinely collected data (June 2020 to January 2022) from a large US academic health system. Dashboard users were compared with contemporaneous nonexposed patients matched on clinical criteria. The primary outcomes were unplanned all-cause hospital admissions, potentially avoidable emergency department visits, excess days in acute care within 30 days of discharge, and 7-day readmissions. Cancer-specific secondary outcomes included acute encounters during outpatient chemotherapy, oncology triage use, advance directive completion, and hospice use. CKD-specific outcomes were CKD-related acute care use and disease progression. RESULTS In the advanced cancer cohort (dashboard users: n=284; dashboard nonusers: n=917), dashboard use was associated with significantly fewer chemotherapy-related emergency department or hospital encounters (ratio-in–odds ratios 0.35, 95% CI 0.16-0.75) and a nonsignificant 1.7–percentage point reduction in unplanned admissions (β=–0.017, 95% CI –0.107 to 0.072). Using Firth penalized logistic regression to reduce small sample bias, dashboard use was also associated with significantly higher odds of 7-day readmissions (ratio-in–odds ratios 8.58, 95% CI 2.28-32.32). Among readmissions in the dashboard user group, most (13/14, 93%) were scheduled by clinicians. Excess days in acute care increased by 4 percentage points (β=0.040, 95% CI –0.001 to 0.089). Advance directive completion declined significantly (β=–0.009, 95% CI –0.039 to 0.020). In the CKD cohort (dashboard users: n=365; dashboard nonusers: n=2137), no significant differences were observed for any primary or CKD-specific outcome. CONCLUSIONS In routine oncology practice, a PRO dashboard was associated with fewer acute care encounters during chemotherapy but more planned early readmissions. The dashboard had no measurable effect on patients with CKD. These disease-specific mixed results highlight the need to tailor dashboards to the clinical context and embed them within workflows that can act on real-time PRO information.